HomeResources

Resources

Injection site reaction assessment of Cetrorelix
12
Jun

CASE STUDY – Cetrorelix & ISR

By Alexandra Comments are Off

Discover how the ImmunoSafe: ISR Platform® support the evaluation of local immune reactions caused by subcutaneous administration of Cetrorelix.

De-risk your injectable therapeutic candidates with ISR Platform
12
Jun

APPLICATION NOTE – ISR

By Alexandra Comments are Off

Explore how the ISR Platform® can effectively de-risk your injectable therapeutic candidates today!

Non clinical toxicity services
12
Jun

APPLICATION NOTE – Non clinical toxicity services

By Alexandra Comments are Off

Discover a quick approach to de-risk your injectable therapeutic candidates using ex vivo live human skin.

InflammaSkin studies for Topical Therapeutics
12
Jun

APPLICATION NOTE – InflammaSkin® studies for topical therapeutics

By Alexandra Comments are Off

Explore InflammaSkin®, a unique T cell-driven skin inflammation platform to test your topical anti-psoriasis formulas.

Efficacy Assessment of Injectable Anti-Psoriasis
12
Jun

APPLICATION NOTE – InflammaSkin® studies for injectable therapeutics

By Alexandra Comments are Off

Uncover InflammaSkin®, a unique T cell-driven skin inflammation platform to test your injecatble anti-psoriasis formulas.

Innovative model system for mast cell research
21
May

Ask the Expert: Your top questions about Genoskin’s mast cell platform answered

By Genoskin Comments are Off

Ask the Expert: Your Top Questions About Genoskin’s Mast Cell Platform Answered Curious about mast cells and their role in injection site reactions? Learn about how Genoskin sources and cultures human primary mast cells, the unique qualities of our mast cell research solution, and its diverse applications in drug toxicity assessment, allergic reaction evaluation, and vaccine development. 1. How do
Read more